You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BLFS Award Disclosure
Mathew Aby J. · SEC Form 4 · Filed Oct 8, 2026
Award
Reported value range
Not reported
Mathew Aby J. EVP & Chief Scientific Officer
BLFS
Transaction date
Oct 6, 2026
Public filing date
Oct 8, 2026
Filing lag
Filed 2 days later
BLFS daily price context
Close on/before transaction
$38.61
Oct 6, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 45,838 shares
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-418315
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$2.7M
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Biolife Solutions Inc BLFS | Disposition | Oct 6, 2026 | Not reported |
| Biolife Solutions Inc BLFS | Disposition | Oct 6, 2026 | $2.7M |
| Biolife Solutions Inc BLFS Current | Award | Oct 6, 2026 | Not reported |
| Biolife Solutions Inc BLFS | Award | Oct 6, 2026 | Not reported |